Medican Enterprises, Inc.

OTC: MDCN · Healthcare · Medical - Pharmaceuticals

PublicHQ Los Angeles, CA · Los AngelesCIK 0000847015Reports USD

#1161 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ 11GM —SS 47

v0.1 · 25/100 weight · pillars only

↑ listing tenure, Altman-Z · ↓ return on assets, balance-sheet leverage

Methodology →

Revenue TTM

$1.6M

Rev growth YoY (TTM)

-62.7%

Net income (FY)

-$56.5M

Employees

as of 2026-08-24

Market cap

$2.9M

as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02012

Net income-$56.5M-$56.5M2014

Operating income-$57.5M-$57.5M2014

Total assets$112.6k$112.6k2014

Liabilities$8.4M$8.4M2014

Equity-$8.3M-$8.3M2014

Revenue trend

FY2011 – FY2012 · USD

FY11

FY12

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Medican Enterprises, Inc.’s revenue?

Medican Enterprises, Inc. booked $0 in FY2012 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

nDatalyze Corp.47D Elixxer Ltd.14D Moleculin Biotech, Inc.42D Autonomix Medical, Inc.28D Eco-Growth Strategies Inc.——Indo Global Exchange(s) PTE, Ltd.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B72B Public Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68B Live Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D

Key facts

CEOMitchell Xavier

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLos Angeles, CA

ExchangeOTC: MDCN

Employees3

IPO date1995-02-21

Latest filings

8-K2017-01-27 8-K2015-10-07 8-K2015-07-15 8-K2015-06-18 10-Q2015-05-20 8-K2015-05-08 8-K2015-05-01 10-K2015-04-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.